中(zhōng)文
|
English
Search
Home
About Us
Return
Company Introduction
Company Qualification
Technical Cooperation
Products
Return
Immunofluorescence
Colloidal Gold
Nucleic Aicd Assay
Detecting Instrument
News
Return
Company News
Industry Information
Solution
Return
Hair Drug Detection
Chest Pain Center
Stroke Center
Endocrine Clinic
Recruitment
Contact Us
Home
About Us
Return
Company Introduction
Company Qualification
Technical Cooperation
Products
Return
Immunofluorescence
Colloidal Gold
Nucleic Aicd Assay
Detecting Instrument
News
Return
Company News
Industry Information
Solution
Return
Hair Drug Detection
Chest Pain Center
Stroke Center
Endocrine Clinic
Recruitment
Contact Us
中(zhōng)文
|
English
none
News
Company News
Industry Information
Your Current Position:
News
The new coronavirus IgM/IgG reagent enters the export "whitelist" of the Ministry of Commerce
2020-05-18
On March 28, 2020, the new crown detection reagent developed by Shengyi Biotechnology obtained the CE mark certificate issued by the Netherlands CIBG.
Our products have obtained the self-test CE certification
2021-08-17
On August 16, 2021, the Polish PCBC Agency International Announcement (Announcement No. 1434): Officially issued the European Union self-test CE certificate of Anbang Biotechnology。
Meet at the 17th CACLP in Nanchang
2021-11-08
On August 23-25, the 17th Nanchang CACLP, Shengyi Biotech's booth number A3-T47, will display the company's latest product achievements. Welcome all industry experts and colleagues to visit and guide!
Good news: the new coronavirus 2019-nCoV nucleic acid determination kit obtains the medical device registration certificate
2020-06-10
After nearly three months of hard work, the Shengyi technology R&D and product registration team successfully developed a new coronavirus nucleic acid detection reagent based on hybrid capture immunofluorescence method
